1. Home
  2. LEGN
  3. LEGN News

Latest Legend Biotech Corporation (LEGN) News on November 17, 2024

Legend Biotech Corporation (NASDAQ:LEGN) Just Released Its Third-Quarter Earnings: Here's What Analysts Think
LEGN

Simply Wall St.

2 days ago

Legend Biotech Corporation (NASDAQ:LEGN) Just Released Its Third-Quarter Earnings: Here's What Analysts Think

Legend Biotech Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
LEGN

Simply Wall St.

3 days ago

Legend Biotech Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

LEGN

Thomson Reuters StreetEvents

5 days ago

Q3 2024 Legend Biotech Corp Earnings Call

Legend Biotech Corp (LEGN) Q3 2024 Earnings Call Highlights: CARVYKTI's Impressive Growth Amid ...
LEGN

GuruFocus.com

5 days ago

Legend Biotech Corp (LEGN) Q3 2024 Earnings Call Highlights: CARVYKTI's Impressive Growth Amid ...

Legend Biotech (LEGN) Reports Q3 Earnings: What Key Metrics Have to Say
LEGN

Zacks

5 days ago

Legend Biotech (LEGN) Reports Q3 Earnings: What Key Metrics Have to Say

LEGN

MT Newswires

5 days ago

Legend Biotech Q3 Loss Widens, Revenue Rises

Legend Biotech Reports Third Quarter 2024 Results and Recent Highlights
LEGN

GlobeNewswire

5 days ago

Legend Biotech Reports Third Quarter 2024 Results and Recent Highlights

Legend Biotech (LEGN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
LEGN

Zacks

6 days ago

Legend Biotech (LEGN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Legend Biotech Corp (LEGN) Q3 2024 Earnings Report Preview: What to Look For
LEGN

GuruFocus.com

6 days ago

Legend Biotech Corp (LEGN) Q3 2024 Earnings Report Preview: What to Look For

Legend Biotech to Host Investor Event During the 66th American Society of Hematology (ASH) Annual Meeting and Exposition
LEGN

GlobeNewswire

10 days ago

Legend Biotech to Host Investor Event During the 66th American Society of Hematology (ASH) Annual Meeting and Exposition

Legend Biotech to Unveil Minimal Residual Disease Data from Landmark CARTITUDE-4 Trial in Multiple Myeloma
LEGN

GlobeNewswire

12 days ago

Legend Biotech to Unveil Minimal Residual Disease Data from Landmark CARTITUDE-4 Trial in Multiple Myeloma

Legend Biotech Appoints Alan Bash as President of CARVYKTI®
LEGN

GlobeNewswire

13 days ago

Legend Biotech Appoints Alan Bash as President of CARVYKTI®

Wall Street Analysts Believe Legend Biotech (LEGN) Could Rally 90.83%: Here's is How to Trade
LEGN

Zacks

24 days ago

Wall Street Analysts Believe Legend Biotech (LEGN) Could Rally 90.83%: Here's is How to Trade

Legend Biotech to Host Investor Conference Call on Third Quarter 2024 Results
LEGN

GlobeNewswire

24 days ago

Legend Biotech to Host Investor Conference Call on Third Quarter 2024 Results

Is Legend Biotech Corporation (LEGN) the Most Promising Biotech Stock According to Hedge Funds?
LEGN

Insider Monkey

a month ago

Is Legend Biotech Corporation (LEGN) the Most Promising Biotech Stock According to Hedge Funds?

LEGN

MT Newswires

a month ago

Redburn Initiates Legend Biotech at Buy With $86 Price Target

LEGN

MT Newswires

a month ago

Legend Biotech to Open New Cell Therapy R&D Facility in Philadelphia

Legend Biotech to Establish New, State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia
LEGN

GlobeNewswire

a month ago

Legend Biotech to Establish New, State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia

High Growth Tech Stocks To Watch In October 2024
LEGN

Simply Wall St.

2 months ago

High Growth Tech Stocks To Watch In October 2024

Legend Biotech Reverses After J&J-Tied Cancer Drug Cuts Risk Of Death By 45%
LEGN

Investor's Business Daily

2 months ago

Legend Biotech Reverses After J&J-Tied Cancer Drug Cuts Risk Of Death By 45%

Legend Biotech Rises After J&J-Tied Cancer Drug Cuts Risk Of Death By 45%
LEGN

Investor's Business Daily

2 months ago

Legend Biotech Rises After J&J-Tied Cancer Drug Cuts Risk Of Death By 45%

CARVYKTI® is the First and Only Cell Therapy to Significantly Extend Overall Survival Compared to Standard of Care in Patients with Multiple Myeloma as Early as Second Line
LEGN

GlobeNewswire

2 months ago

CARVYKTI® is the First and Only Cell Therapy to Significantly Extend Overall Survival Compared to Standard of Care in Patients with Multiple Myeloma as Early as Second Line

Legend Biotech's J&J-Partnered Drug Cut The Risk Of Death By 45% In Multiple Myeloma
LEGN

Investor's Business Daily

2 months ago

Legend Biotech's J&J-Partnered Drug Cut The Risk Of Death By 45% In Multiple Myeloma

Legend Biotech Corporation (LEGN): Among Hedge Funds’ Top Biotech Stock Picks
LEGN

Insider Monkey

2 months ago

Legend Biotech Corporation (LEGN): Among Hedge Funds’ Top Biotech Stock Picks

Here’s Why TimesSquare Capital Management U.S. Focus Growth Strategy Removed Legend Biotech Corporation (LEGN) from its Portfolio
LEGN

Insider Monkey

2 months ago

Here’s Why TimesSquare Capital Management U.S. Focus Growth Strategy Removed Legend Biotech Corporation (LEGN) from its Portfolio

Matthews Emerging Markets Small Companies Fund Boosts Stake in Legend Biotech Corp
LEGN

GuruFocus.com

2 months ago

Matthews Emerging Markets Small Companies Fund Boosts Stake in Legend Biotech Corp

Exploring 3 High Growth Tech Stocks In The United States
LEGN

Simply Wall St.

2 months ago

Exploring 3 High Growth Tech Stocks In The United States

LEGN

MT Newswires

3 months ago

Legend Biotech Says China's National Medical Products Administration Approves Cell Therapy Product to Treat Multiple Myeloma

Legend Biotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
LEGN

GlobeNewswire

3 months ago

Legend Biotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Here's What Analysts Are Forecasting For Legend Biotech Corporation (NASDAQ:LEGN) After Its Second-Quarter Results
LEGN

Simply Wall St.

3 months ago

Here's What Analysts Are Forecasting For Legend Biotech Corporation (NASDAQ:LEGN) After Its Second-Quarter Results

LEGN

MT Newswires

3 months ago

Sector Update: Health Care Stocks Edge Higher Pre-Bell Friday

LEGN

MT Newswires

3 months ago

Legend Biotech's Q2 Loss Narrows, Revenue Climbs

Legend Biotech Reports Second Quarter 2024 Results and Recent Highlights
LEGN

GlobeNewswire

3 months ago

Legend Biotech Reports Second Quarter 2024 Results and Recent Highlights

Legend Biotech Appoints Peter Salovey, Ph.D., to its Board of Directors
LEGN

GlobeNewswire

3 months ago

Legend Biotech Appoints Peter Salovey, Ph.D., to its Board of Directors

Is Legend Biotech Corporation (LEGN) a Good Growth Stock to Buy?
LEGN

Insider Monkey

4 months ago

Is Legend Biotech Corporation (LEGN) a Good Growth Stock to Buy?

LEGN

MT Newswires

4 months ago

Legend Biotech Reports Preliminary First-Half Financial Results

Legend Biotech Announces Preliminary Results for the Six-Months Ended June 30, 2024
LEGN

GlobeNewswire

4 months ago

Legend Biotech Announces Preliminary Results for the Six-Months Ended June 30, 2024

LEGN

MT Newswires

4 months ago

TD Cowen Adjusts Legend Biotech Price Target to $67 From $71, Maintains Buy Rating

Legend Biotech (LEGN) Up 12% on Reports of Takeover Bid
LEGN

Zacks

4 months ago

Legend Biotech (LEGN) Up 12% on Reports of Takeover Bid

Legend Biotech (LEGN) Surges 12.1%: Is This an Indication of Further Gains?
LEGN

Zacks

4 months ago

Legend Biotech (LEGN) Surges 12.1%: Is This an Indication of Further Gains?

Legend Biotech to Host Investor Conference Call on Second Quarter 2024 Results
LEGN

GlobeNewswire

4 months ago

Legend Biotech to Host Investor Conference Call on Second Quarter 2024 Results

LEGN

MT Newswires

5 months ago

Legend Biotech Says Myeloma Drug Shows Positive Overall Survival Results

Legend Biotech Announces Positive Overall Survival Results of Landmark Phase 3 CARTITUDE-4 Trial in Multiple Myeloma
LEGN

GlobeNewswire

5 months ago

Legend Biotech Announces Positive Overall Survival Results of Landmark Phase 3 CARTITUDE-4 Trial in Multiple Myeloma

Does Legend Biotech (LEGN) Have a Long Runway for Growth?
LEGN

Insider Monkey

5 months ago

Does Legend Biotech (LEGN) Have a Long Runway for Growth?

LEGN

MT Newswires

5 months ago

Truist Securities Initiates Legend Biotech With Buy Rating, $88 Price Target

LEGN

MT Newswires

5 months ago

Legend Biotech Says Phase 2 Trial of Carvykti to Treat Multiple Myeloma Showed 'Deep, Durable' Responses

Legend Biotech Shares Data on the Earliest Use to Date of CARVYKTI® in the Treatment of Multiple Myeloma and Important Subgroup Analyses at ASCO and EHA
LEGN

Business Wire

5 months ago

Legend Biotech Shares Data on the Earliest Use to Date of CARVYKTI® in the Treatment of Multiple Myeloma and Important Subgroup Analyses at ASCO and EHA

Legend Biotech to Participate in the Jefferies Global Healthcare Conference
LEGN

Business Wire

6 months ago

Legend Biotech to Participate in the Jefferies Global Healthcare Conference

LEGN

MT Newswires

6 months ago

HC Wainwright Adjusts Legend Biotech Price Target to $73 From $86, Maintains Buy Rating

LEGN

MT Newswires

6 months ago

Deutsche Bank Starts Legend Biotech With Buy Rating

Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA
LEGN

Business Wire

6 months ago

Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA

LEGN

MT Newswires

6 months ago

MaxCyte Signs License Deal With Legend Biotech for Cell Therapy Program

LEGN

MT Newswires

6 months ago

HC Wainwright Adjusts Price Target on Legend Biotech to $86 From $87, Keeps Buy Rating

LEGN

MT Newswires

6 months ago

RBC Adjusts Price Target on Legend Biotech to $86 From $85 on Model Updates, Maintains Outperform Rating

LEGN

GuruFocus.com

6 months ago

Legend Biotech Corp (LEGN) Q1 2024 Earnings Call Transcript Highlights: Soaring CARVYKTI Sales ...

LEGN

Thomson Reuters StreetEvents

6 months ago

Q1 2024 Legend Biotech Corp Earnings Call

LEGN

MT Newswires

6 months ago

Sector Update: Health Care Stocks Decline Pre-Bell Monday

LEGN

MT Newswires

6 months ago

Sector Update: Health Care

LEGN

MT Newswires

6 months ago

Legend Biotech Q1 Net Loss Narrows as Revenue Rises; Shares Rise Pre-Bell

Legend Biotech Reports First Quarter 2024 Results and Recent Highlights
LEGN

Business Wire

6 months ago

Legend Biotech Reports First Quarter 2024 Results and Recent Highlights

Should You Buy Legend Biotech (LEGN) Ahead of Earnings?
LEGN

Zacks

6 months ago

Should You Buy Legend Biotech (LEGN) Ahead of Earnings?

LEGN

MT Newswires

7 months ago

Legend Biotech's Carvykti Gets European Commission Approval for Treatment of Blood Cancer

CARVYKTI® (ciltacabtagene autoleucel) Approved by the European Commission for Second-line Treatment of Patients with Relapsed and Refractory Multiple Myeloma
LEGN

Business Wire

7 months ago

CARVYKTI® (ciltacabtagene autoleucel) Approved by the European Commission for Second-line Treatment of Patients with Relapsed and Refractory Multiple Myeloma

Legend Biotech to Host Investor Conference Call on First Quarter 2024 Results
LEGN

Business Wire

7 months ago

Legend Biotech to Host Investor Conference Call on First Quarter 2024 Results

FDA Expands J&J's (JNJ) Carvykti Label in Multiple Myeloma
LEGN

Zacks

7 months ago

FDA Expands J&J's (JNJ) Carvykti Label in Multiple Myeloma

Why Legend Biotech (LEGN) Stock Might be a Great Pick
LEGN

Zacks

7 months ago

Why Legend Biotech (LEGN) Stock Might be a Great Pick

LEGN

Reuters

7 months ago

U.S. FDA approves expanded use of J&J's cancer cell therapy

Legend Biotech’s CARVYKTI® (ciltacabtagene autoleucel) Becomes the First and Only BCMA-Targeted CAR-T Cell Therapy Approved by the FDA for Second-Line Treatment of Multiple Myeloma
LEGN

Business Wire

7 months ago

Legend Biotech’s CARVYKTI® (ciltacabtagene autoleucel) Becomes the First and Only BCMA-Targeted CAR-T Cell Therapy Approved by the FDA for Second-Line Treatment of Multiple Myeloma

Should You Continue to Hold Legend Biotech Corporation (LEGN)?
LEGN

Insider Monkey

7 months ago

Should You Continue to Hold Legend Biotech Corporation (LEGN)?

Management’s Conservative Guidance Led Legend Biotech Corporation (LEGN) to Decline in Q4
LEGN

Insider Monkey

8 months ago

Management’s Conservative Guidance Led Legend Biotech Corporation (LEGN) to Decline in Q4

Legend Biotech Announces Publication of Inaugural Environmental, Social and Governance (ESG) Report
LEGN

Business Wire

8 months ago

Legend Biotech Announces Publication of Inaugural Environmental, Social and Governance (ESG) Report

30 Biggest Biotechnology Companies in the World
LEGN

Insider Monkey

8 months ago

30 Biggest Biotechnology Companies in the World

CARVYKTI® (ciltacabtagene autoleucel) Receives Recommendation from the U.S. FDA Oncologic Drugs Advisory Committee for Earlier Treatment of Patients with Relapsed/Refractory Multiple Myeloma
LEGN

Business Wire

8 months ago

CARVYKTI® (ciltacabtagene autoleucel) Receives Recommendation from the U.S. FDA Oncologic Drugs Advisory Committee for Earlier Treatment of Patients with Relapsed/Refractory Multiple Myeloma

Legend Biotech Corporation (NASDAQ:LEGN) Q4 2023 Earnings Call Transcript
LEGN

Insider Monkey

8 months ago

Legend Biotech Corporation (NASDAQ:LEGN) Q4 2023 Earnings Call Transcript

The Zacks Analyst Blog Highlights Legend Biotech, Exact Sciences, Exelixis, Ascendis Pharma and MorphoSys
LEGN

Zacks

8 months ago

The Zacks Analyst Blog Highlights Legend Biotech, Exact Sciences, Exelixis, Ascendis Pharma and MorphoSys

Legend Biotech Reports Fourth Quarter and Full Year 2023 Results and Recent Highlights
LEGN

Business Wire

8 months ago

Legend Biotech Reports Fourth Quarter and Full Year 2023 Results and Recent Highlights

5 Biotechnology Stocks to Buy for a Stable Portfolio in 2024
LEGN

Zacks

8 months ago

5 Biotechnology Stocks to Buy for a Stable Portfolio in 2024

An Intrinsic Calculation For Legend Biotech Corporation (NASDAQ:LEGN) Suggests It's 47% Undervalued
LEGN

Simply Wall St.

9 months ago

An Intrinsic Calculation For Legend Biotech Corporation (NASDAQ:LEGN) Suggests It's 47% Undervalued

Legend Biotech Announces Positive CHMP Opinion for CARVYKTI® (ciltacabtagene autoleucel) for the Treatment of Patients with Relapsed and Lenalidomide Refractory Multiple Myeloma in Earlier Lines of Therapy
LEGN

Business Wire

9 months ago

Legend Biotech Announces Positive CHMP Opinion for CARVYKTI® (ciltacabtagene autoleucel) for the Treatment of Patients with Relapsed and Lenalidomide Refractory Multiple Myeloma in Earlier Lines of Therapy

Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2023 Results
LEGN

Business Wire

9 months ago

Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2023 Results

Matthews Emerging Markets Small Companies Fund Bolsters Position in CarTrade Tech Ltd
LEGN

GuruFocus.com

9 months ago

Matthews Emerging Markets Small Companies Fund Bolsters Position in CarTrade Tech Ltd

Carlisle Receives First-Ever LEED Platinum v4 Certification in North America
LEGN

Business Wire

10 months ago

Carlisle Receives First-Ever LEED Platinum v4 Certification in North America

Analysts Estimate StepStone Group Inc. (STEP) to Report a Decline in Earnings: What to Look Out for
LEGN

Zacks

10 months ago

Analysts Estimate StepStone Group Inc. (STEP) to Report a Decline in Earnings: What to Look Out for

Equity LifeStyle Properties, Inc. (NYSE:ELS) Q4 2023 Earnings Call Transcript
LEGN

Insider Monkey

10 months ago

Equity LifeStyle Properties, Inc. (NYSE:ELS) Q4 2023 Earnings Call Transcript

LEGN

South China Morning Post

10 months ago

Ant Group inks strategic partnership with Shanghai to help the city's AI ambitions

LEGN

South China Morning Post

10 months ago

Alibaba, Tencent gain as Hong Kong stocks snap 2-day slump on China data while markets eye Fed rate cut in May

Avery Dennison (AVY) Reports Q4 Earnings: What Key Metrics Have to Say
LEGN

Zacks

10 months ago

Avery Dennison (AVY) Reports Q4 Earnings: What Key Metrics Have to Say

LEGN

Reuters

10 months ago

UPDATE 1-Southwest prepared to wait for delayed Boeing MAX 7s, executive says

Southwest prepared to wait for delayed Boeing MAX 7s, executive says
LEGN

Reuters

10 months ago

Southwest prepared to wait for delayed Boeing MAX 7s, executive says

Global Electric Commercial Vehicle Battery Market Report 2023-2030: Demand, Regional Share, Technology Roadmap, Cost Dynamics, Price Forecasts, and Profiles of Major Battery Cell Suppliers
LEGN

GlobeNewswire

10 months ago

Global Electric Commercial Vehicle Battery Market Report 2023-2030: Demand, Regional Share, Technology Roadmap, Cost Dynamics, Price Forecasts, and Profiles of Major Battery Cell Suppliers

Zacks Industry Outlook Highlights Publicis Groupe, Omnicom Group and WPP
LEGN

Zacks

10 months ago

Zacks Industry Outlook Highlights Publicis Groupe, Omnicom Group and WPP

Alabama’s Shelby County Commission to Deploy NICE’s Market Leading Digital Evidence Management Platform to Transform Criminal Justice
LEGN

Business Wire

10 months ago

Alabama’s Shelby County Commission to Deploy NICE’s Market Leading Digital Evidence Management Platform to Transform Criminal Justice

What Is Owens Corning's (NYSE:OC) Share Price Doing?
LEGN

Simply Wall St.

10 months ago

What Is Owens Corning's (NYSE:OC) Share Price Doing?

Best Buy's (NYSE:BBY) earnings trajectory could turn positive as the stock climbs 6.0% this past week
LEGN

Simply Wall St.

10 months ago

Best Buy's (NYSE:BBY) earnings trajectory could turn positive as the stock climbs 6.0% this past week

Is Live Nation Entertainment, Inc. (NYSE:LYV) Potentially Undervalued?
LEGN

Simply Wall St.

10 months ago

Is Live Nation Entertainment, Inc. (NYSE:LYV) Potentially Undervalued?

DraftKings to Release Fourth Quarter and Full Year 2023 Results on February 15, 2024 and Host Conference Call on February 16, 2024
LEGN

GlobeNewswire

10 months ago

DraftKings to Release Fourth Quarter and Full Year 2023 Results on February 15, 2024 and Host Conference Call on February 16, 2024

Warren Buffett Bolsters Holdings in Liberty SiriusXM Group
LEGN

GuruFocus.com

10 months ago

Warren Buffett Bolsters Holdings in Liberty SiriusXM Group

DraftKings, Barstool deal would 'make a lot of sense': Analyst
LEGN

Yahoo Finance Video

10 months ago

DraftKings, Barstool deal would 'make a lot of sense': Analyst

Jabil Declares Quarterly Dividend
LEGN

Business Wire

10 months ago

Jabil Declares Quarterly Dividend

LEGN

Reuters

10 months ago

CORRECTED-UPDATE 1-Xcel Energy posts higher Q4 profit on lower operating expenses

Share on Social Networks: